Skip to main content

Table 2 Details of A. baumannii isolates, by sequence type

From: Molecular epidemiology of bla OXA-23 -producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China

     Non-susceptible to (%): Resistant determinants
ST No. Allelic profile Time course IPM TZP TCC CAZ AMK LVX MNO
191 32 1-3-3-2-2-94-3 Aug. 2009
Feb. 2011–May. 2012
100 100 100 100 38 100 23 OXA-51, OXA-23, AMPC
195 31 1-3-3-2-2-96-3 Mar. 2013–Nov. 2014 100 100 100 100 97 100 100 OXA-51, OXA-23, AMPC
208 15 1-3-3-2-2-97-3 Jul. 2010–Oct. 2014 100 100 100 93 100 100 100 OXA-51, OXA-23, AMPC
218 2 1-3-3-2-2-102-3 Jul. 2011–Aug. 2011 100 100 100 100 100 100 0 OXA-51, OXA-23, AmpC
368 6 1-3-3-2-2-140-3 Jun. 2009–Sep. 2014 100 100 100 100 67 67 33 OXA-51, OXA-23, AmpC
369 1 1-3-3-2-2-106-3 Jun. 2013 100 100 100 100 0 100 - OXA-51, OXA-23, AmpC
373 2 1-12-12-11-4-103-3 Mar. 2011, Apr. 2011 100 100 100 100 0 100 0 OXA-51, AmpC
383 2 1-12-56-1-4-149-45 Aug. 2011 100 100 100 100 100 100 100 OXA-51, AmpC
429 2 1-34-56-1-4-144-45 Jul. 2011, Sep. 2011 100 100 100 100 50 50 100 OXA-51, OXA-23, AmpC
469 6 1-12-3-2-2-103-3 Dec. 2012-Nov. 2013 100 100 100 100 100 100 100 OXA-51, OXA-23, AmpC
1302n 1 2-52-80-6-23-140-4 Jul. 2014 100 100 100 0 0 0 0 OXA-51, OXA-40, AmpC
1309n 1 27-155n-99-55-25 -270n-60 Aug. 2011 100 100 100 100 100 100 100 OXA-51, AmpC
Total 101 - Jun. 2009–Nov. 2014 100 100 100 98 80 96 68 -
  1. nNovel; IPM imipenem, TZP piperacillin/tazobactam, TCC ticarcillin/clavulanic acid, CAZ ceftazidime, AMK amikacin, LVX levofloxacin, MNO minocycline